Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2026 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy|FCC Public Files

Back to Press Play with Madeleine Brand

Press Play with Madeleine Brand

Diabetes drug Ozempic is costing Medicare billions of dollars

New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.

    • Share
    By Jonathan Bastian • Mar 27, 2024 • 1 min read

    New analysis from the Kaiser Family Foundation shows that Medicare spending on weight loss drugs like Ozempic rose to $5.7 billion in 2022 — up from $57 million in 2018.

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Jonathan Bastian

      Host, Life Examined

    • KCRW placeholder

      Sarah Sweeney

      Vice President of Talk Programming, KCRW

    • KCRW placeholder

      Angie Perrin

      Producer, Press Play

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Amy Ta

      Digital News & Culture Editor

    • KCRW placeholder

      Juliette Cubanski

      deputy director of the Kaiser Family Foundation’s program on Medicare policy

      NewsHealth & WellnessNationalBusiness & Economy
    Back to Press Play with Madeleine Brand